Mustang Bio (MBIO)
(Delayed Data from NSDQ)
$1.58 USD
+0.01 (0.64%)
Updated Oct 2, 2025 04:00 PM ET
After-Market: $1.55 -0.03 (-1.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MBIO 1.58 +0.01(0.64%)
Will MBIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MBIO
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy
MBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MBIO
Is MBIO positioned for a breakout? Crossed Above 20 Day Moving Average shows up after advancing 3.29%
MBIO Fell Below 20 Day Moving Average on October 1
MBIO's price falls by 1.26% on September 29, though its technical setup remains stable.
Is MBIO poised for a breakout? NR7 shows up after slipping 0.63%
MBIO forms Narrow Range Bar on September 25